Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease

NCT01951326 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

331

Enrollment

INDUSTRY

Sponsor class

Conditions

Crohn's Disease

Interventions

DRUG: RHB-104
DRUG: Placebo

Sponsor

RedHill Biopharma Limited